How to upgrade to the MiniMed™ 780G system

Man remotely upgrading to the MiniMed™ 780G system

Remote upgrade to MiniMed™ 780G system no longer available
 

As part of our ongoing efforts to enhance the software upgrade experience, we’ve discontinued the Medtronic Diabetes Updater app, effective April 25, 2025. While we work on our software upgrade process, you will have the option to upgrade your insulin pump through our program offerings.

For more details, view our device upgrade options.

What to do next

 

  • If you have an in-warranty MiniMed™ 770G system and have instructions to complete the software upgrade, please complete before April 25, 2025.
  • If you have not upgraded to the MiniMed™ 780G pump and have an in-warranty MiniMed™ 770G system, place your order on Diabetes.shop.
  • If you already upgraded to the MiniMed™ 780G pump, you can delete the app.
     

Future upgrades


If you would like to upgrade your MiniMed™ 770G pump after April 25, 2025, please contact us at 800-646-4633 and select option 3 (Monday - Friday, 8:00 a.m. to 7:00 p.m. CT) to discuss your available options.
 

Frequently Asked Questions
 

Why is the Diabetes Updater app being discontinued?

The Updater app will be discontinued globally on April 25, 2025, as part of our efforts to enhance the software upgrade process and improve the overall app experience for our customers.
 

How will I be able to upgrade my tech in the future? 

After April 25, 2025, you can upgrade your technology when your product is out-of-warranty or through one of our programs. For more details, view our current programs.
 

Do I need to delete the app from my phone? 

We recommend that you only keep the Diabetes Updater app on your phone when you are completing a software upgrade on your MiniMed™ 770G pump. If you have already upgraded to the MiniMed™ 780G pump, you can delete the app. If you have not upgraded to the MiniMed™ 780G pump, complete the upgrade prior to April 25, 2025.

After April 25, 2025, the Updater app will no longer work, and we recommend deleting it.
 

What if I decide I want to upgrade my MiniMed™ 770G system after the app is no longer available? 

To upgrade your MiniMed™ 770G pump after April 25, 2025, we’ll first need to check its warranty status. If your pump is still under warranty, you can upgrade to the MiniMed™ 780G system through our Pathway Program for $399. If it’s out of warranty, you can upgrade to the MiniMed™ 780G system with the Guardian™ 4 sensor through your insurance. Call us at 800-646-4633, option 3 (Monday to Friday, 8:00 a.m. to 7:00 p.m. CT) to explore your options.
 

 
 
MiniMed 780G system with SmartGuard technology with Guardian 4 Sensor
The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 780G System includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. 
The Medtronic MiniMed 780G System consists of the following devices: MiniMed 780G Insulin Pump, the Guardian 4 Transmitter, the Guardian 4 Sensor, One-press serter, the Accu-Chek Guide Link blood glucose meter, and the Accu-Chek Guide Test Strips. The system requires a prescription from a healthcare professional.
The Guardian 4 Sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian (4) sensor is indicated for up to seven days of continuous use. 
The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor. The Guardian 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
WARNING: Do not use the SmartGuard feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard feature.
 
WARNING: Do not use the MiniMed 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.

 

MiniMed 770G system with SmartGuard technology

The MiniMed 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 770G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. 

The Medtronic MiniMed 770G System consists of the following devices: MiniMed 770G Insulin Pump, the Guardian Link (3) Transmitter, the Guardian Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide Test Strips. The system requires a prescription. 

The Guardian Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. 

All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian Sensor (3). All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard Auto Mode for people who require less than eight units or more than 250 units of total daily insulin per day. A total daily dose of at least eight units, but no more than 250 units, is required to operate in SmartGuard Auto Mode.

 

WARNING: Do not use the MiniMed 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library

 

Related Articles

About Author